ALFA Finder| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Total income | 22.3 | 31.6 | 31.3 |
| Exceptional items | 0.5 | 0.0 | 0.0 |
| Net profit | 1.4 | 2.1 | 1.5 |
| Operating margin | 7.2% | 8.9% | 7.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -6.70% |
|---|---|
| Net profit, quarter on quarter | -33.30% |
BSE results filing, NSE: SMRUTHI. Figures extracted from the filing.
Smruthi Organics Ltd: key numbers
- Share price
- ₹168.80
- Market cap
- ₹193.2 Cr
- Revenue (annual)
- ₹102.0 Cr
- Net profit (annual)
- ₹3.43 Cr
- P/E (TTM)
- 27.4×Sector 43.7×
- Promoter holding
- 64.73%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Smruthi Organics Ltd
All →Smruthi Organics Q2 FY27 Results: Net Profit ₹1.7 Cr, Down 19.0% YoY
Smruthi Organics approved unaudited financial results for the quarter and half year ended 30 September 2026. The statutory auditors issued an unmodified limited review conclusion.
- Key figure
- Net profit ₹1.7 Cr · -19.0% YoY
Smruthi Organics Business Update
Smruthi Organics received the Brazilian GMP (CBPF) certificate for its Unit II API, Levamlodipine Besylate Hemi pentahydrate. This strengthens its regulatory presence in the Brazilian pharmaceutical market.
Smruthi Organics Board Meeting Date
Smruthi Organics has scheduled a board meeting on 13 November 2026 to approve unaudited Q2 results for the quarter ended 30 September 2026. The trading window stays closed until 48 hours after results are declared.
Smruthi Organics Business Update
Smruthi Organics received ANVISA's GMP report for Unit II, classifying it as Complies with Corrective Action. The final GMP certificate remains pending.
Smruthi Organics Management Change
Smruthi Organics received Central Government approval for the appointment of Ms. Smruthi Purushotham Eaga as Whole-time Director for three years starting June 2026.
Smruthi Organics Other Announcement
Smruthi Organics Ltd filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Regulation 31.